Keigi Fujiwara Selected Research

RNA (Ribonucleic Acid)

9/2014

Intima modifier locus 2 controls endothelial cell activation and vascular permeability.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Keigi Fujiwara Research Topics

Disease

11	Inflammation (Inflammations) 12/2021 - 09/2010
9	Atherosclerosis 01/2019 - 05/2011
4	Neoplasms (Cancer) 11/2021 - 01/2018
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2019 - 10/2012
3	Atherosclerotic Plaque (Atheroma) 01/2018 - 03/2013
2	Bites and Stings (Sting) 01/2020 - 01/2017
2	Hypertension (High Blood Pressure) 03/2016 - 10/2012
2	Myocardial Infarction 10/2012 - 02/2012
1	Vascular Diseases (Vascular Disease) 12/2021
1	Coronary Artery Disease (Coronary Atherosclerosis) 11/2021
1	Mitochondrial Diseases (Mitochondrial Disease) 11/2021
1	Chromosome Aberrations (Chromosome Abnormalities) 09/2020
1	Rupture 01/2020
1	Genomic Instability 09/2019
1	Cardiac Arrhythmias (Arrythmia) 01/2017
1	Epilepsy (Aura) 01/2017
1	Obesity 01/2017
1	Diabetes Mellitus 01/2013
1	Reperfusion Injury 10/2012
1	Type 2 Diabetes Mellitus (MODY) 10/2012
1	Heart Failure 10/2012
1	Infarction (Infarctions) 01/2012
1	Fibrosis (Cirrhosis) 11/2011

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2012
4	Phosphotransferases (Kinase)IBA 01/2020 - 03/2015
3	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2021 - 01/2012
3	Pharmaceutical PreparationsIBA 01/2019 - 10/2012
2	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2021 - 01/2018
2	Interferon Regulatory Factor-3 (Interferon Regulatory Factor 3)IBA 01/2020 - 01/2017
2	InterferonsIBA 01/2020 - 01/2017
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2014 - 07/2014
2	Ligases (Synthetase)IBA 02/2013 - 02/2012
1	Focal Adhesion Protein-Tyrosine KinasesIBA 12/2021
1	Adenosine Triphosphate (ATP)IBA 11/2021
1	NAD (NADH)IBA 11/2021
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 11/2021
1	CarbonIBA 09/2020
1	DNA (Deoxyribonucleic Acid)IBA 01/2020
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 01/2020
1	Mitochondrial DNA (mtDNA)IBA 01/2020
1	Messenger RNA (mRNA)IBA 01/2020
1	Angiotensin IIIBA 01/2020
1	IonsIBA 09/2019
1	Guanylate KinasesIBA 01/2019
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	Cisplatin (Platino)FDA LinkGeneric 01/2018
1	InflammasomesIBA 01/2017
1	Nonesterified Fatty Acids (NEFA)IBA 01/2017
1	Potassium Channels (Potassium Channel)IBA 01/2017
1	Palmitic Acid (Hexadecanoic Acid)IBA 01/2017
1	Nitric Oxide Synthase (NO Synthase)IBA 03/2016
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 03/2016
1	LipidsIBA 03/2015
1	Antimalarials (Antimalarial Agents)IBA 10/2014
1	RNA (Ribonucleic Acid)IBA 09/2014
1	LDL Receptors (LDL Receptor)IBA 07/2014
1	CholesterolIBA 07/2014
1	Peptide Hydrolases (Proteases)FDA Link 03/2013
1	SUMO-1 Protein (SUMO Protein)IBA 03/2013
1	EnzymesIBA 03/2013
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 02/2013
1	KetonesIBA 01/2013
1	EkoIBA 01/2013
1	90-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 90 kDa)IBA 01/2013
1	Mitogen-Activated Protein Kinase 7IBA 01/2013
1	Apolipoproteins E (ApoE)IBA 01/2013
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 01/2013
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 10/2012
1	Lipoproteins (Lipoprotein)IBA 10/2012
1	Glucagon-Like Peptide 1 (GLP 1)IBA 10/2012
1	IncretinsIBA 10/2012
1	Dipeptidyl-Peptidase IV InhibitorsIBA 10/2012
1	UbiquitinIBA 02/2012
1	ThioredoxinsIBA 02/2012
1	Kruppel-Like Transcription Factors (Kruppel-Like Factors)IBA 02/2012
1	HDL CholesterolIBA 01/2012
1	Isoproterenol (Isoprenaline)FDA LinkGeneric 11/2011
1	Protein Kinase CIBA 05/2011
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2010

Therapy/Procedure

2	Therapeutics 11/2021 - 01/2018
1	Highly Active Antiretroviral Therapy (HAART) 01/2019
1	Radiotherapy 01/2018
1	Ligation 01/2018